An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2
- 5 July 2001
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 20 (30), 4041-4049
- https://doi.org/10.1038/sj.onc.1204533
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 37 references indexed in Scilit:
- Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like KinaseJournal of Biological Chemistry, 2000
- Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cellsOncogene, 1998
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.Genes & Development, 1997
- Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential.Genes & Development, 1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- The p53-mdm-2 autoregulatory feedback loop.Genes & Development, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992